The AVENIO family of next-generation sequencing (NGS) oncology assays comprises three liquid biopsy assays and three new corresponding tissue assays with matched panel content. New AVENIO Tumor Tissue Analysis Kits, together with AVENIO ctDNA Analysis Kits, offer a uniquely versatile solution for comprehensive genomic profiling, longitudinal monitoring and concordance analysis of solid tumors from tissue and plasma samples.